Mylan Inc (MYL) 76.06 $MYL
TEVA Acquisition Of Mylan Would Produce Generic Powerhouse
Alpha Gen Capital - at Seeking Alpha - Sat Apr 25, 8:23AM CDT
PRGO: 192.89 (-8.74), MYL: 76.06 (+2.37), TEVA: 64.41 (+1.16), ASPX: 100.88 (-0.01)
Perrigo rebuffs Mylan again
at Investor's Business Daily - Fri Apr 24, 6:12PM CDT
Over-the-counter pharma company Perrigo rejected generic-drug maker Mylan's (MYL) hostile $30-bil-plus acquisition bid. Perrigo said the bid was "significantly below" Mylan's prior offer that it had rejected as too low. Mylan's latest proposal would...
MYL: 76.06 (+2.37), TEVA: 64.41 (+1.16)
Mylan 'Raises' Perrigo Bid, But Teva Buzz Builds
at Investor's Business Daily - Fri Apr 24, 4:51PM CDT
Seeking to avoid being a takeover itself, Mylan (MYL) raised its offer for Perrigo (PRGO), which promptly rejected the bid, saying the proposal was worse than before. Generic drugmaker Mylan bid $60 cash and 2.2 Mylan shares for each share of...
ABT: 48.32 (-0.14), PRGO: 192.89 (-8.74), WBA: 85.98 (-0.71), WMT: 79.84 (+0.66), MYL: 76.06 (+2.37), TEVA: 64.41 (+1.16)
S&P 500, Nasdaq Notch New Records as Amazon, Microsoft Jump
at The Street - Fri Apr 24, 3:08PM CDT
The S&P 500 and the Nasdaq close the week at all-time highs thanks to an earnings-driven rally.
BIIB: 401.71 (-28.57), F: 15.77 (+0.01), PRGO: 192.89 (-8.74), CHTR: 185.75 (+2.17), XOM: 86.97 (-0.57), JBLU: 19.89 (+0.14), JNPR: 26.14 (+2.14), SBUX: 51.84 (+2.41), GOOGL: 573.66 (+16.20), TWC: 155.26 (+6.50), MSFT: 47.87 (+4.53), TWTR: 50.82 (-0.59), AAPL: 130.28 (+0.61), GPRO: 44.73 (-1.35), AMZN: 445.10 (+55.11), VFC: 73.70 (-0.21), MYL: 76.06 (+2.37), XRX: 11.99 (-1.15), DWA: 26.00 (+0.25), EXPE: 98.89 (-0.03), YELP: 50.61 (+0.29), CMCSA: 59.64 (+0.41)
Seeking Alpha's Biotech Weekly: Gilead Isn't Perfect, Biogen-Bass, Spring Fever, And More
SA Editor Mike Taylor - Seeking Alpha - Fri Apr 24, 3:00PM CDT
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. This week, contributors grappled with deals real and imagined, industry competition...
BIIB: 401.71 (-28.57), VRTX: 133.20 (-2.62), PRGO: 192.89 (-8.74), PFE: 35.27 (-0.09), CLDN: 13.68 (-0.26), MYL: 76.06 (+2.37), OREX: 7.36 (-0.08), JNJ: 101.08 (+0.62), NVO: 56.65 (+0.44), TNXP: 6.52 (-0.15), ALNY: 119.01 (+0.29), GILD: 103.69 (-1.52), SGEN: 37.14 (-0.36), ACHN: 10.06 (+0.06), MRK: 57.60 (+0.09), GALE: 1.45 (+0.02), JUNO: 56.66 (-1.06), SNY: 51.75 (-0.01), NBY: 0.63 (unch), XLRN: 33.29 (-0.95)
S&P 500 Hits Intraday Record as Time Warner Cable Spikes
at The Street - Fri Apr 24, 2:30PM CDT
Stocks are higher late Friday, boosted by a rally in shares of Amazon, Google and Microsoft.
AMZN: 445.10 (+55.11), BIIB: 401.71 (-28.57), PRGO: 192.89 (-8.74), CHTR: 185.75 (+2.17), XOM: 86.97 (-0.57), COP: 67.51 (-0.75), MYL: 76.06 (+2.37), XRX: 11.99 (-1.15), JNPR: 26.14 (+2.14), SBUX: 51.84 (+2.41), RDS.A: 62.76 (-0.20), TOT: 51.87 (-0.45), AAL: 52.71 (+1.26), GOOGL: 573.66 (+16.20), TWC: 155.26 (+6.50), MSFT: 47.87 (+4.53), CMCSA: 59.64 (+0.41), XLE: 81.98 (-0.47)
Perrigo Rejects Mylan Unsolicited Offer
PR Newswire - Fri Apr 24, 11:09AM CDT
Perrigo Company plc ("Perrigo" or the "Company"
(NYSE: PRGO, TASE) today announced its rejection of the unsolicited offer from Mylan NV ("Mylan" (NASDAQ: MYL) to acquire all of the outstanding shares of Perrigo for $60.00 per share in cash and 2.2 Mylan ordinary shares for each ordinary Perrigo share (the "Offer".
PRGO: 192.89 (-8.74), MYL: 76.06 (+2.37)
Google, Amazon Lift Tech Sector as Nasdaq Hovers in Record Territory
at The Street - Fri Apr 24, 9:55AM CDT
The Nasdaq and S&P 500 hover at record highs.
AMZN: 445.10 (+55.11), BIIB: 401.71 (-28.57), PRGO: 192.89 (-8.74), MYL: 76.06 (+2.37), XRX: 11.99 (-1.15), SBUX: 51.84 (+2.41), AAL: 52.71 (+1.26), GOOGL: 573.66 (+16.20), TWC: 155.26 (+6.50), MSFT: 47.87 (+4.53), CMCSA: 59.64 (+0.41)
Mylan (MYL) Stock Gains Today After Increasing Second Perrigo Bid to $33 Billion
at The Street - Fri Apr 24, 9:37AM CDT
Mylan (MYL) shares are climbing after the company announced a $33 billion bid for rival Perrigo (PRGO), the second offer for the company it made this week.
MYL: 76.06 (+2.37)
Watch for Shares of Mylan (MYL) to Approach Resistance at $74.98
Comtex SmarTrend(R) - Fri Apr 24, 9:08AM CDT
Mylan (NASDAQ:MYL) has opened bullishly above the pivot of $73.17 today and has reached the first level of resistance at $74.34. Analysts will be watching for a cross of the next upside pivot targets of $74.98 and $76.79.
MYL: 76.06 (+2.37)
Mylan commences formal offer for Perrigo
Seeking Alpha - at Seeking Alpha - Fri Apr 24, 8:58AM CDT
PRGO: 192.89 (-8.74), MYL: 76.06 (+2.37)
Mylan To Commence Formal Offer To Acquire Perrigo For US$60 In Cash And 2.2 Mylan Shares Per Perrigo Share
PR Newswire - Fri Apr 24, 8:44AM CDT
On 8 April 2015, Mylan N.V. (NASDAQ: MYL) issued a Rule 2.4 announcement under the Irish Takeover Rules stating that it had made a non-binding proposal to acquire Perrigo (NYSE: PRGO; TASE) for US$205 in a combination of cash and Mylan stock for each Perrigo share. The Rule 2.4 announcement followed the delivery of that proposal to Perrigo's Chairman on 6 April 2015.
PRGO: 192.89 (-8.74), MYL: 76.06 (+2.37)
Next Week In Biotech: Gilead, Celgene Report; PDUFAs For Theravance, The Medicines Co.
SA Editor Mike Taylor - Seeking Alpha - Fri Apr 24, 8:00AM CDT
Every Friday morning, Seeking Alpha posts a calendar of the next week's expected biotech events to start a forward-looking conversation. Please be aware that dates and events can be subject to change. Please let us know in a comment or message if you...
VRX: 210.42 (+1.03), BMRN: 120.28 (-2.67), UTHR: 186.69 (-1.87), CLDX: 30.10 (+0.19), ACOR: 33.12 (-0.38), AFFX: 12.44 (-0.16), HSP: 87.61 (-0.05), OXGN: 1.48 (unch), MACK: 13.42 (-0.25), HBIO: 6.22 (+0.08), ECYT: 6.17 (-0.13), GEVA: 108.51 (+0.92), CYTR: 5.13 (-0.13), THRX: 17.92 (+0.46), FF: 11.18 (+0.03), MDXG: 9.81 (-0.39), EXEL: 3.08 (-0.02), VRTX: 133.20 (-2.62), NEO: 4.75 (-0.11), PFE: 35.27 (-0.09), INCY: 107.34 (-0.51), MYL: 76.06 (+2.37), AMGN: 167.91 (-1.26), ANIK: 38.35 (-0.32), ALKS: 62.26 (-1.19), ONTY: 1.74 (-0.05), CELG: 118.71 (+2.62), NBIX: 43.37 (-0.31), SGEN: 37.14 (-0.36), OGXI: 2.19 (+0.04), EBIO: 11.19 (+0.69), ABAX: 63.62 (+0.31), GILD: 103.69 (-1.52), GERN: 4.30 (-0.03), HAE: 43.35 (+0.74), MRK: 57.60 (+0.09), TEVA: 64.41 (+1.16), PCRX: 85.07 (+0.80)
Mylan Chooses Its Own Adventure
Chris DeMuth Jr. - at Seeking Alpha - Thu Apr 23, 2:27PM CDT
PRGO: 192.89 (-8.74), MYL: 76.06 (+2.37), TEVA: 64.41 (+1.16)
Shares of MYL Up 12.5% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Apr 23, 11:32AM CDT
SmarTrend identified an Uptrend for Mylan (NASDAQ:MYL) on April 8th, 2015 at $65.11. In approximately 2 weeks, Mylan has returned 12.54% as of today's recent price of $73.27.
MYL: 76.06 (+2.37)
Mylan Launches Generic Sofosbuvir Tablets, MyHep(TM), in India
PR Newswire - Thu Apr 23, 4:00AM CDT
Mylan N.V. (Nasdaq: MYL) today announced that its subsidiary, Mylan Pharmaceuticals Private Limited, has launched generic Sofosbuvir 400 mg tablets under the brand name MyHep(TM) in India. The product is indicated for the treatment of chronic hepatitis C, a blood-borne infectious disease that affects more than 100 million people in the developing world, including approximately 12 million people in India.1,2
MYL: 76.06 (+2.37)
Will Teva Manage To Complete The Takeover Of Mylan?
Emerging Equities - at Seeking Alpha - Wed Apr 22, 4:44PM CDT
PRGO: 192.89 (-8.74), MYL: 76.06 (+2.37), TEVA: 64.41 (+1.16), ASPX: 100.88 (-0.01)
Don't Cash In On Perrigo Yet, Upside Still Possible
Value Hawk - Seeking Alpha - Wed Apr 22, 4:27PM CDT
Summary: We recommend a sell for Perrigo Company (NYSE: PRGO ) with two triggers based on the possible scenarios. First, if Perrigo's price falls to $185, we recommend selling to protect significant gains from recent M&A conversations. On the...
PRGO: 192.89 (-8.74), MYL: 76.06 (+2.37), TEVA: 64.41 (+1.16)
Teva Proposes to Buy Mylan, Sends Shares Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 22, 1:11PM CDT
Teva (TEVA) made an offer to acquire Mylan (MYL) for $82 per share in a deal that would create a powerhouse of generics with revenues of more than $30 billion.
ACT: 295.41 (-2.95), PRGO: 192.89 (-8.74), MYL: 76.06 (+2.37), TEVA: 64.41 (+1.16)
Abbott Labs (ABT) Beats on Q1 Earnings, View Reiterated - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 22, 12:18PM CDT
Abbott Laboratories (ABT) reported first-quarter 2015 earnings of 47 cents per share, up 38.2% from the year-ago quarter and beat the Zacks Consensus Estimate of 42 cents.
ABT: 48.32 (-0.14), VRX: 210.42 (+1.03), SHPG: 255.11 (-0.26), MYL: 76.06 (+2.37)
TEVA Acquisition Of Mylan Would Produce Generic Powerhouse
Alpha Gen Capital - at Seeking Alpha - Sat Apr 25, 8:23AM CDT
PRGO: 192.89 (-8.74), MYL: 76.06 (+2.37), TEVA: 64.41 (+1.16), ASPX: 100.88 (-0.01)
Perrigo rebuffs Mylan again
at Investor's Business Daily - Fri Apr 24, 6:12PM CDT
Over-the-counter pharma company Perrigo rejected generic-drug maker Mylan's (MYL) hostile $30-bil-plus acquisition bid. Perrigo said the bid was "significantly below" Mylan's prior offer that it had rejected as too low. Mylan's latest proposal would...
MYL: 76.06 (+2.37), TEVA: 64.41 (+1.16)
Mylan 'Raises' Perrigo Bid, But Teva Buzz Builds
at Investor's Business Daily - Fri Apr 24, 4:51PM CDT
Seeking to avoid being a takeover itself, Mylan (MYL) raised its offer for Perrigo (PRGO), which promptly rejected the bid, saying the proposal was worse than before. Generic drugmaker Mylan bid $60 cash and 2.2 Mylan shares for each share of...
ABT: 48.32 (-0.14), PRGO: 192.89 (-8.74), WBA: 85.98 (-0.71), WMT: 79.84 (+0.66), MYL: 76.06 (+2.37), TEVA: 64.41 (+1.16)
S&P 500, Nasdaq Notch New Records as Amazon, Microsoft Jump
at The Street - Fri Apr 24, 3:08PM CDT
The S&P 500 and the Nasdaq close the week at all-time highs thanks to an earnings-driven rally.
BIIB: 401.71 (-28.57), F: 15.77 (+0.01), PRGO: 192.89 (-8.74), CHTR: 185.75 (+2.17), XOM: 86.97 (-0.57), JBLU: 19.89 (+0.14), JNPR: 26.14 (+2.14), SBUX: 51.84 (+2.41), GOOGL: 573.66 (+16.20), TWC: 155.26 (+6.50), MSFT: 47.87 (+4.53), TWTR: 50.82 (-0.59), AAPL: 130.28 (+0.61), GPRO: 44.73 (-1.35), AMZN: 445.10 (+55.11), VFC: 73.70 (-0.21), MYL: 76.06 (+2.37), XRX: 11.99 (-1.15), DWA: 26.00 (+0.25), EXPE: 98.89 (-0.03), YELP: 50.61 (+0.29), CMCSA: 59.64 (+0.41)
Seeking Alpha's Biotech Weekly: Gilead Isn't Perfect, Biogen-Bass, Spring Fever, And More
SA Editor Mike Taylor - Seeking Alpha - Fri Apr 24, 3:00PM CDT
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. This week, contributors grappled with deals real and imagined, industry competition...
BIIB: 401.71 (-28.57), VRTX: 133.20 (-2.62), PRGO: 192.89 (-8.74), PFE: 35.27 (-0.09), CLDN: 13.68 (-0.26), MYL: 76.06 (+2.37), OREX: 7.36 (-0.08), JNJ: 101.08 (+0.62), NVO: 56.65 (+0.44), TNXP: 6.52 (-0.15), ALNY: 119.01 (+0.29), GILD: 103.69 (-1.52), SGEN: 37.14 (-0.36), ACHN: 10.06 (+0.06), MRK: 57.60 (+0.09), GALE: 1.45 (+0.02), JUNO: 56.66 (-1.06), SNY: 51.75 (-0.01), NBY: 0.63 (unch), XLRN: 33.29 (-0.95)
S&P 500 Hits Intraday Record as Time Warner Cable Spikes
at The Street - Fri Apr 24, 2:30PM CDT
Stocks are higher late Friday, boosted by a rally in shares of Amazon, Google and Microsoft.
AMZN: 445.10 (+55.11), BIIB: 401.71 (-28.57), PRGO: 192.89 (-8.74), CHTR: 185.75 (+2.17), XOM: 86.97 (-0.57), COP: 67.51 (-0.75), MYL: 76.06 (+2.37), XRX: 11.99 (-1.15), JNPR: 26.14 (+2.14), SBUX: 51.84 (+2.41), RDS.A: 62.76 (-0.20), TOT: 51.87 (-0.45), AAL: 52.71 (+1.26), GOOGL: 573.66 (+16.20), TWC: 155.26 (+6.50), MSFT: 47.87 (+4.53), CMCSA: 59.64 (+0.41), XLE: 81.98 (-0.47)
Perrigo Rejects Mylan Unsolicited Offer
PR Newswire - Fri Apr 24, 11:09AM CDT
Perrigo Company plc ("Perrigo" or the "Company"
(NYSE: PRGO, TASE) today announced its rejection of the unsolicited offer from Mylan NV ("Mylan" (NASDAQ: MYL) to acquire all of the outstanding shares of Perrigo for $60.00 per share in cash and 2.2 Mylan ordinary shares for each ordinary Perrigo share (the "Offer". PRGO: 192.89 (-8.74), MYL: 76.06 (+2.37)
Google, Amazon Lift Tech Sector as Nasdaq Hovers in Record Territory
at The Street - Fri Apr 24, 9:55AM CDT
The Nasdaq and S&P 500 hover at record highs.
AMZN: 445.10 (+55.11), BIIB: 401.71 (-28.57), PRGO: 192.89 (-8.74), MYL: 76.06 (+2.37), XRX: 11.99 (-1.15), SBUX: 51.84 (+2.41), AAL: 52.71 (+1.26), GOOGL: 573.66 (+16.20), TWC: 155.26 (+6.50), MSFT: 47.87 (+4.53), CMCSA: 59.64 (+0.41)
Mylan (MYL) Stock Gains Today After Increasing Second Perrigo Bid to $33 Billion
at The Street - Fri Apr 24, 9:37AM CDT
Mylan (MYL) shares are climbing after the company announced a $33 billion bid for rival Perrigo (PRGO), the second offer for the company it made this week.
MYL: 76.06 (+2.37)
Watch for Shares of Mylan (MYL) to Approach Resistance at $74.98
Comtex SmarTrend(R) - Fri Apr 24, 9:08AM CDT
Mylan (NASDAQ:MYL) has opened bullishly above the pivot of $73.17 today and has reached the first level of resistance at $74.34. Analysts will be watching for a cross of the next upside pivot targets of $74.98 and $76.79.
MYL: 76.06 (+2.37)
Mylan commences formal offer for Perrigo
Seeking Alpha - at Seeking Alpha - Fri Apr 24, 8:58AM CDT
PRGO: 192.89 (-8.74), MYL: 76.06 (+2.37)
Mylan To Commence Formal Offer To Acquire Perrigo For US$60 In Cash And 2.2 Mylan Shares Per Perrigo Share
PR Newswire - Fri Apr 24, 8:44AM CDT
On 8 April 2015, Mylan N.V. (NASDAQ: MYL) issued a Rule 2.4 announcement under the Irish Takeover Rules stating that it had made a non-binding proposal to acquire Perrigo (NYSE: PRGO; TASE) for US$205 in a combination of cash and Mylan stock for each Perrigo share. The Rule 2.4 announcement followed the delivery of that proposal to Perrigo's Chairman on 6 April 2015.
PRGO: 192.89 (-8.74), MYL: 76.06 (+2.37)
Next Week In Biotech: Gilead, Celgene Report; PDUFAs For Theravance, The Medicines Co.
SA Editor Mike Taylor - Seeking Alpha - Fri Apr 24, 8:00AM CDT
Every Friday morning, Seeking Alpha posts a calendar of the next week's expected biotech events to start a forward-looking conversation. Please be aware that dates and events can be subject to change. Please let us know in a comment or message if you...
VRX: 210.42 (+1.03), BMRN: 120.28 (-2.67), UTHR: 186.69 (-1.87), CLDX: 30.10 (+0.19), ACOR: 33.12 (-0.38), AFFX: 12.44 (-0.16), HSP: 87.61 (-0.05), OXGN: 1.48 (unch), MACK: 13.42 (-0.25), HBIO: 6.22 (+0.08), ECYT: 6.17 (-0.13), GEVA: 108.51 (+0.92), CYTR: 5.13 (-0.13), THRX: 17.92 (+0.46), FF: 11.18 (+0.03), MDXG: 9.81 (-0.39), EXEL: 3.08 (-0.02), VRTX: 133.20 (-2.62), NEO: 4.75 (-0.11), PFE: 35.27 (-0.09), INCY: 107.34 (-0.51), MYL: 76.06 (+2.37), AMGN: 167.91 (-1.26), ANIK: 38.35 (-0.32), ALKS: 62.26 (-1.19), ONTY: 1.74 (-0.05), CELG: 118.71 (+2.62), NBIX: 43.37 (-0.31), SGEN: 37.14 (-0.36), OGXI: 2.19 (+0.04), EBIO: 11.19 (+0.69), ABAX: 63.62 (+0.31), GILD: 103.69 (-1.52), GERN: 4.30 (-0.03), HAE: 43.35 (+0.74), MRK: 57.60 (+0.09), TEVA: 64.41 (+1.16), PCRX: 85.07 (+0.80)
Mylan Chooses Its Own Adventure
Chris DeMuth Jr. - at Seeking Alpha - Thu Apr 23, 2:27PM CDT
PRGO: 192.89 (-8.74), MYL: 76.06 (+2.37), TEVA: 64.41 (+1.16)
Shares of MYL Up 12.5% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Apr 23, 11:32AM CDT
SmarTrend identified an Uptrend for Mylan (NASDAQ:MYL) on April 8th, 2015 at $65.11. In approximately 2 weeks, Mylan has returned 12.54% as of today's recent price of $73.27.
MYL: 76.06 (+2.37)
Mylan Launches Generic Sofosbuvir Tablets, MyHep(TM), in India
PR Newswire - Thu Apr 23, 4:00AM CDT
Mylan N.V. (Nasdaq: MYL) today announced that its subsidiary, Mylan Pharmaceuticals Private Limited, has launched generic Sofosbuvir 400 mg tablets under the brand name MyHep(TM) in India. The product is indicated for the treatment of chronic hepatitis C, a blood-borne infectious disease that affects more than 100 million people in the developing world, including approximately 12 million people in India.1,2
MYL: 76.06 (+2.37)
Will Teva Manage To Complete The Takeover Of Mylan?
Emerging Equities - at Seeking Alpha - Wed Apr 22, 4:44PM CDT
PRGO: 192.89 (-8.74), MYL: 76.06 (+2.37), TEVA: 64.41 (+1.16), ASPX: 100.88 (-0.01)
Don't Cash In On Perrigo Yet, Upside Still Possible
Value Hawk - Seeking Alpha - Wed Apr 22, 4:27PM CDT
Summary: We recommend a sell for Perrigo Company (NYSE: PRGO ) with two triggers based on the possible scenarios. First, if Perrigo's price falls to $185, we recommend selling to protect significant gains from recent M&A conversations. On the...
PRGO: 192.89 (-8.74), MYL: 76.06 (+2.37), TEVA: 64.41 (+1.16)
Teva Proposes to Buy Mylan, Sends Shares Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 22, 1:11PM CDT
Teva (TEVA) made an offer to acquire Mylan (MYL) for $82 per share in a deal that would create a powerhouse of generics with revenues of more than $30 billion.
ACT: 295.41 (-2.95), PRGO: 192.89 (-8.74), MYL: 76.06 (+2.37), TEVA: 64.41 (+1.16)
Abbott Labs (ABT) Beats on Q1 Earnings, View Reiterated - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 22, 12:18PM CDT
Abbott Laboratories (ABT) reported first-quarter 2015 earnings of 47 cents per share, up 38.2% from the year-ago quarter and beat the Zacks Consensus Estimate of 42 cents.
ABT: 48.32 (-0.14), VRX: 210.42 (+1.03), SHPG: 255.11 (-0.26), MYL: 76.06 (+2.37)
